Sagent Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT, and what generic and branded alternatives to SAGENT drugs are available?
SAGENT has eighty-eight approved drugs.
There is one tentative approval on SAGENT drugs.
Drugs and US Patents for Sagent
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sagent Pharms Inc | ZOLEDRONIC ACID | zoledronic acid | INJECTABLE;INTRAVENOUS | 091493-001 | Nov 24, 2014 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | CISATRACURIUM BESYLATE | cisatracurium besylate | INJECTABLE;INJECTION | 201836-001 | Nov 6, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | INJECTABLE;INJECTION | 074617-001 | Feb 28, 1996 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms | OXACILLIN SODIUM | oxacillin sodium | INJECTABLE;INJECTION | 091246-001 | Mar 30, 2012 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | EPHEDRINE SULFATE | ephedrine sulfate | SOLUTION;INTRAVENOUS | 214528-001 | Mar 9, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 209077-003 | Jul 20, 2018 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.